- Title
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- Creators
- Mark R. Rigby (Author)Kristina M. Harris (Author)Ashley Pinckney (Author)Linda A. DiMeglio (Author)Marc S. Rendell (Author) - Creighton UniversityEric I. Felner (Author)Jean M. Dostou (Author)Stephen E. Gitelman (Author)Kurt J. Griffin (Author)Eva Tsalikian (Author)Peter A. Gottlieb (Author)Carla J. Greenbaum (Author)Nicole A., . . . Immune Tolerance Network ITN TIDAL Sherry (Author)
- Additional links
- http://doi.org/10.1172/JCI81722
- Publication Details
- Journal of Clinical Investigation, Vol.125(8), pp.3285-3296
- Number of pages
- 3285-3296
- Identifiers
- 991005931569802656
- Academic Unit
- School of Medicine; Endocrine
- Language
- English
- Resource Type
- Journal article
Journal article
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
Journal of Clinical Investigation, Vol.125(8), pp.3285-3296
08/2015
PMID: 26193635
Metrics
8 Record Views